Table 2.
Serum TNF-α, IL-18 and IL-10 levels in patients treated with Huaiqihuang granule combined with hormone (group A), hormone alone (group B), and the control patients (group C)
| Groups | Before/After treatment | TNF-α (pg/mL) | IL-18 (pg/mL) | IL-10 (pg/mL) |
|---|---|---|---|---|
| C group (25 cases) | NA | 175.47±31.84 | 63.14±24.51 | 16.34±5.46 |
| A group (33 cases) | Before treatment | 231.45±62.57 | 117.35±42.14 | 11.53±3.81 |
| After 3 months of treatment | 176.33±46.951 | 95.84±17.521,2 | 12.43±2.54 | |
| After 6 months of treatment | 174.65±52.131 | 98.24±17.621,2 | 13.81±3.14 | |
| B group(30 cases) | Before treatment | 234.26±46.37 | 121.41±24.17 | 11.42±2.11 |
| After 3 months of treatment | 186.34±48.64 | 108.82±22.142 | 6.39±1.951,2,3 | |
| After 6 months of treatment | 179.85±67.35 | 115.34±18.922 | 7.62±2.831,2,3 |
Note: 1. Compared with those before treatment in the same group, P < 0.05; 2. Compared with the normal control group, P < 0.05; 3. Compared with the same period of Huaiqihuang granule group, P < 0.05. TNF= Tumor Necrosis Factor; IL=Interleukin; NA=Not applicable.